Rare Disease Report

Grants Awarded for Hemophilia Research

AUGUST 01, 2016
Andrew Blac
The Bayer Hemophilia Awards Program (BHAP) gave out grants to 6 researchers/clinicians from hospitals and research institutions across the United States.
BHAP was initiated by Bayer in 2002 and is the largest program involved with funding for Hemophilia research and studies.  To date, it has awarded more than 255 grants totaling in excess of $31 million to researchers and caregivers from 32 countries around the world.


BHAP awardees are selected by a global panel of distinguished hemophilia clinicians, researchers and caregivers. The program’s support has contributed to more than 500 publications, poster presentations and other scientific communications by awardees. In 2016, 16 recipients in 11 countries received grants worth nearly $2 million.
This year’s U.S BHAP winners were announced at the World Federation of Hemophilia World Congress 2016 (WFH) in Orlando, Florida.
The U.S. BHAP winners are:
  • Dr. Moanaro Biswas, University of Florida Cancer & Genetics Research Center

Dr. Moanaro Biswas is apart of the Cellular and Molecular Therapy department at the University of Florida Cancer and Genetics Research Center.

  • Dr. James Dahlman, Georgia Institute of Technology-
Dr. James Dahlman is a chemical and bioengineer whose work lies at the interface of nanotechnology, genomics, and gene editing. He studied in vivo gene editing at the Broad Institute of Harvard and MIT; he received his Ph.D. from MIT and Harvard Medical School. 

  • Dr. Gary Gilbert, Boston VA Research Institute – 
Dr. Gary Gilbert, M.D. is the Deputy Associate Chief of Staff for Research and Development at the VA Boston Healthcare System. He oversees the basic science activities at all three campuses and has charge of major initiatives to import new technical capabilities and build a major expansion of the animal facilities He also serves as a member of BVARI’s Board of Directors.  Dr. Gilbert is Associate Physician in Medicine, Brigham and Women’s Hospital and the Associate Professor of Medicine, Harvard medical School.

  • Dr. Rahul Khanna, University of Mississippi-
Dr. Khanna teaches Pharmacoepidemiology to graduate students in the pharmacy administration department, and Introduction to Pharmacy and Healthcare System to professional pharmacy students. Dr. Khanna has varied research interests including claims database analysis, patient reported outcomes, and health behavior theory. 

  • Dr. Michael Milone, University of Pennsylvania -
Dr. Michael Milone’s specialty division is laboratory medicine, Immunobiology and experimental pathology. His research expertise includes aiming toward improving cancer and transplantation therapy through the development of new immunotherapeutic modalities.  His clinical laboratory expertise includes toxicology, therapeutic drug monitoring, clinical chemistry, blood banking/transfusion medicine and therapeutic apheresis.

  • Dr. Maurizio Tomaiuolo, University of Pennsylvania –
Dr. Tomaiuolo is a Senior Research Investigator at the Perelman School of Medicine at The University of Pennsylvania.

Stay informed on the latest rare disease news and developments by signing up for our newsletter.
Copyright © RareDR 2013-2018 Rare Disease Communications. All Rights Reserved.